Discover 520 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
for
Prostate Adenocarcinoma
Location: Madison WI, Chicago IL, Durham NC, Los Angeles CA
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18+
Code: NCT06022822
Phase 2, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Madison WI, Milwaukee WI, Park Ridge IL, Green Bay WI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
for
Acute Myeloid Leukemia With FLT3/ITD Mutation,
Location: Madison WI, Columbus OH, Chapel Hill NC,
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT06222580
Phase 1, Recruiting
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Get alerts for new trials in your area by subscribing now
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for
Angioimmunoblastic T-cell Lymphoma,
Location: Madison WI, DeKalb IL, Lake Forest IL, Geneva IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT04803201
Phase 2, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
for
Melanoma (Skin Cancer),
Location: Madison WI, Maple Grove MN, Detroit MI, Cincinnati OH,
Sponsor: Aminex Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07287917
Phase 1, Phase 2, Recruiting
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
for
Metastatic Malignant Solid Neoplasm,
Location: Madison WI, Chicago IL, St Louis MO, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05372614
Phase 1, Recruiting
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
for
Hematologic Malignancies
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18 - 70+
Code: NCT07285668
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Madison WI, Chicago IL, Kansas City KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase 1, Recruiting
(Peak) A Phase 3 Randomized Trial of Bezuclastinib (CGT9486)+Sunitinib vs. Sunitinib in Participants With Gastrointestinal Stromal Tumors
for
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
Location: Madison WI, Chicago IL, Iowa City IA, Rochester MN,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05208047
Phase 3, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: Madison WI, Oconomowoc WI, Mukwonago WI, Waukesha WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase 3, Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Madison WI, West Bend WI, Menomonee Falls WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase 3, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Madison WI, Chicago IL, Rochester MN, St Louis MO,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Madison WI, Oconomowoc WI, Mukwonago WI, Waukesha WI,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Madison WI, Milwaukee WI, Highland Park IL, Glenview IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Madison WI, Orland Park IL, Chicago IL, Rochester MN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT05854498
Phase 2, Recruiting
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer (CRPC),
Location: Madison WI
Sponsor: TechnoGenesys, Inc.
Sex: Male
Age: 18+
Code: NCT06705686
Phase 1, Recruiting
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer